Back to search
FDAFDA · Food and drugs·Recall number D-1336-2022

Launch Sequence Capsules, Dietary Supplement, 60- count bottles, ASIN B07TLPWXDS, UPC Code 641378938375.

Published July 27, 2022 · Recall initiated: June 27, 2022

Summary

FDA records drug Class I recall D-1336-2022, published July 27, 2022 and initiated June 27, 2022. Recalling firm: Loud Muscle Science; Status: Terminated; Reported quantity: 5,421 60-count bottles; Lot: Lot# 20212001, Exp. Date 12/2024. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Loud Muscle Science
Distributor
The product was distributed nationwide in the USA and Canada.
UPC
641378938375
Lot
Lot# 20212001, Exp. Date 12/2024
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Launch Sequence Capsules, Dietary Supplement, 60- count bottles, ASIN B07TLPWXDS, UPC Code 641378938375. recalled?

Yes. FDA published recall D-1336-2022 on July 27, 2022. Reported hazard: Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 641378938375.